Member Comments are provided by individuals and reflect their personal opinions only. Under NO circumstances should you act on any advice or opinion posted in this forum. ALWAYS check with your personal physician before taking any action regarding your health! MedHelp International and our partners, sponsors and affiliates have no obligation to monitor any comments posted on this site, or the content and/or accuracy of such exchanges. MedHelp International does not endorse the views of any user.
This patient support community is for discussions relating to cancer, cancer staging, chemotherapy, hormonal therapy, radiation therapy, surgery, and tumor types.
Mood: April2 has to go to work tonight. Sigh. After work, it's party at my house! Burrpatch is providing the coffee! Journal Entry: "This one is for you, PrettyKitty!
Well,..." [Read]
Mood: April2 has to go to work tonight. Sigh. After work, it's party at my house! Burrpatch is providing the coffee! Journal Entry: "This one is for you, PrettyKitty!
Well,..." [Read]
Mood: April2 has to go to work tonight. Sigh. After work, it's party at my house! Burrpatch is providing the coffee! Journal Entry: "This one is for you, PrettyKitty!
Well,..." [Read]
Mood: April2 has to go to work tonight. Sigh. After work, it's party at my house! Burrpatch is providing the coffee! Journal Entry: "This one is for you, PrettyKitty!
Well,..." [Read]
Unfortunately this type of tumor is not well-studied- there have been issues regarding classification and hence, the actual benefit of chemotherapy is difficult to measure.
The decision will call for a value judgment.
Using chemotherapy now will likely translate into a longer period of time before the disease returns, but there is no clear translation into cure (this is a very controversial statement I am making - this is because, since this is a rare disease the statistics are not so robust. Further, the few studies performed involve other similar tumor types, not exclusively MPNST, so the merit of the results is difficult to apply to specific cases). This means, the side effects of treatment will be taken, but if she goes through life without the feared relapse - we won't really know if the chemotherapy made any difference. Hence, this approach is aggressive, in the sense that she will be risking more, with an uncertainty of how large a benefit she will be gaining by doing so. Another problem is that when she relapses - she will have less options - because the best drugs have been used for the disease already. Hopefully by then, newer drugs are available - at present there is a promising new drug - but drug development is a lot less for these rarer tumors (put coldly, most pharmaceutical companies wouldn't invest in a drug for a disease affecting only a few).
The alternative scenario is to reserve the chemotherapy when the disease returns and it is no longer amenable to local treatment (another surgery or radiation). This is a more conservative approach, because there will be a clear indication for chemotherapy, with a measurable goal.
There is no right or wrong answer here, there are only choices based on what you think is acceptable or not.
Hope this post helped more than it confuses.
When you say she will have less options does that mean chemotherapy can not be administered more than once? With the new promising drug, is this something that is used outside of the US?
God Bless
Noelle